Edition:
India

Croda International PLC (CRDA.L)

CRDA.L on London Stock Exchange

6,264.00GBp
23 Oct 2020
Change (% chg)

88.00 (+1.42%)
Prev Close
6,176.00
Open
6,168.00
Day's High
6,298.00
Day's Low
6,163.28
Volume
194,445
Avg. Vol
266,917
52-wk High
6,510.00
52-wk Low
3,814.00

Latest Key Developments (Source: Significant Developments)

Croda Buys Avanti Polar Lipids For $185 Mln
Monday, 6 Jul 2020 

July 6 (Reuters) - Croda International PLC ::CRODA INTERNATIONAL - CRODA ACQUISITION OF AVANTI POLAR LIPIDS, INC.CRODA - PROPOSED DEAL FOR AN INITIAL CONSIDERATION OF $185M ON A DEBT AND CASH-FREE BASIS,.CRODA - ON COMPLETION, AVANTI WILL CONTINUE TO OPERATE UNDER ITS EXISTING BRAND, LED BY CURRENT MANAGEMENT TEAM.CRODA - AVANTI WILL BECOME A PART OF CRODA'S LIFE SCIENCES SECTOR.CRODA - ACQUISITION IS BEING FINANCED BY A THREE-YEAR TERM LOAN, MAINTAINING CRODA'S STRONG LIQUIDITY.CRODA - PROPOSED DEAL HAS ADDITIONAL EARNOUT OF UP TO $75M BASED ON NEAR-TERM COMMERCIAL OPPORTUNITIES USING AVANTI'S LIPID-BASED SOLUTIONS.  Full Article

Croda International Says US-China Trade War Significantly Impacted Demand
Wednesday, 24 Jul 2019 

July 24 (Reuters) - Croda International PLC ::H1 ADJUSTED PRETAX PROFIT FELL 2.5 PERCENT TO 170.6 MILLION STG.INTERIM DIVIDEND INCREASED BY 3.9% TO 39.5 PENCE..HY CORE BUSINESS SALES 657.9 MILLION STG VERSUS 642.2 MILLION STG.CRODA - PERSONAL CARE SIGNIFICANTLY IMPACTED BY US/CHINA TRADE DISPUTE AND NEW SALES LEGISLATION IN CHINA, SAW GROWTH ACROSS REST OF SECTOR.CRODA - LIFE SCIENCES IS EXPECTED TO SHOW CONTINUED PROGRESS AND IN PERSONAL CARE WE ANTICIPATE US REMAINING SUBDUED WHILE ASIA RECOVERS PROGRESSIVELY.OVERALL WE EXPECT A SLIGHT IMPROVEMENT IN PERFORMANCE IN SECOND HALF OF YEAR VERSUS PRIOR YEAR COMPARATOR.TRADE WAR BETWEEN US AND CHINA SIGNIFICANTLY IMPACTED DEMAND, AS CUSTOMERS CUT INVENTORIES DUE TO UNCERTAIN TARIFF SITUATION.  Full Article

Croda Says Co Progresses Contingency Plans For A 'Hard Brexit'
Tuesday, 26 Feb 2019 

Feb 26 (Reuters) - Croda International PLC ::FY ADJUSTED PROFIT BEFORE TAX 331.5 MILLION POUNDS VERSUS. 320.3 MILLION POUNDS AS REPORTED LAST YEAR.FY SALES - CORE BUSINESS 1,268.7 MILLION POUNDS VERSUS. 1,246.1 MILLION POUNDS AS REPORTED LAST YEAR.DECLARES SPECIAL DIVIDEND OF 115 PENCE PER SHARE IN FY.PROPOSED FULL YEAR ORDINARY DIVIDEND INCREASED BY 7.4% TO 87.0 PENCE PER SHARE.WITH 96% OF SALES AND 80% OF PRODUCTION OUTSIDE UK, IMPACT OF UK LEAVING EU IS EXPECTED TO BE LIMITED FOR CRODA.PROTECTING OUR ABILITY TO MANUFACTURE PRODUCT IN UK AND TO SHIP TO CUSTOMERS, HAVE BEEN ELEMENTS OF CONTINGENCY PLANNING.AN ORDERLY TRANSITION OF UK OUT OF EU IS EXPECTED TO BE MANAGEABLE FOR CRODA.GIVEN UNCERTAINTY OVER METHOD AND TIMING OF UK'S EXIT FROM EU, WE HAVE PROGRESSED CONTINGENCY PLANS FOR A 'HARD BREXIT'.HAVE MADE MINOR CHANGES TO OUR TRADING MODEL WITHIN EUROPE.REVIEWING WHICH PORTS ARE BEST PLACED TO PROTECT SERVICE LEVELS, ENSURING HAVE FULL EU RECOGNITION FOR IMPORTS AND EXPORTS.WORKING TO MITIGATE SUPPLY ISSUES IF THERE ARE DELAYS AT BORDERS.SECURED ADDITIONAL WAREHOUSING CAPACITY & ARE BUILDING FINISHED GOODS INVENTORY IN DISTRIBUTION NETWORK IN CONTINENTAL EUROPE.HAVE ALSO DEVELOPED A PLAN TO PROTECT CRITICAL RAW MATERIALS.DECIDED TO CEASE ISSUING QUARTERLY TRADING UPDATES FROM 2019 ONWARDS.  Full Article

Croda International Says Acquisition Of Vaccine Adjuvant Specialist
Wednesday, 2 Jan 2019 

Jan 2 (Reuters) - Croda International PLC ::ACQUISITION OF MARKET LEADING VACCINE ADJUVANT SPECIALIST.PROPOSED DEAL FOR TOTAL CONSIDERATION OF EUR 72 MILLION IN CASH.ACQUISITION OF BRENNTAG BIOSECTOR (BIOSECTOR).  Full Article

Brenntag AG Sells Biosector To Croda For 72 Mln Euros
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Brenntag Ag ::SELLS NON-CORE ENTITY BIOSECTOR.HAS SIGNED AN AGREEMENT TO DIVEST BRENNTAG BIOSECTOR A/S, DENMARK, TO CRODA INTERNATIONAL PLC FOR A TOTAL CONSIDERATION OF 72 MILLION EUR..THE TRANSACTION IS EXPECTED TO CLOSE BY THE END OF 2018..  Full Article

Croda International To Buy Brenntag Biosector For EUR 72 Mln
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Croda International PLC ::ACQUISITION OF GLOBAL VACCINE ADJUVANT SPECIALIST.TOTAL CONSIDERATION IS EUR 72 MILLION IN CASH AND TRANSACTION IS EXPECTED TO CLOSE BY END OF 2018.DEFINITIVE AGREEMENT HAS BEEN SIGNED WITH BRENNTAG NORDIC A/S TO ACQUIRE BRENNTAG BIOSECTOR A/S.ON COMPLETION, BIOSECTOR WILL BE INTEGRATED INTO CRODA'S HEALTH CARE BUSINESS WITHIN LIFE SCIENCES SECTOR.BIOSECTOR WIL CONTINUE TO BE LED BY ITS TEAM.  Full Article